论文部分内容阅读
目的奥沙利铂配合替吉奥治疗贲门癌的临床有效性评价。方法采用数字随机的方法,把2015年7月至2016年7月时间段内我院收治的贲门癌患者60例划分为两组(对照组=30例,给予卡培他滨联合奥沙利铂治疗方法;研究组=30例,给予奥沙利铂配合替吉奥治疗方法),并对最终的治疗效果进行分析和对比。结果研究组在缓解率方面显著优于对照组(对照组和研究组治疗缓解率分别为70%和83.3%),两组数据有差异(P<0.05),有统计学意义。研究组在不良反应率方面显著低于对照组(对照组和研究组的不良反应率分别为13.3%和3.3%)。结论奥沙利铂配合替吉奥在贲门癌治疗中,有效性高,缓解率高,值得在临床中大力推广和应用。
Objective To evaluate the clinical efficacy of oxaliplatin in treatment of gastric cardia cancer. Methods Sixty patients with cardia cancer who were admitted to our hospital from July 2015 to July 2016 were divided into two groups (control group = 30 cases, capecitabine combined with oxaliplatin Treatment group; study group = 30 cases, given oxaliplatin treatment for Gioia), and the final treatment effect analysis and comparison. Results The study group was significantly better than the control group in remission rate (response rate was 70% and 83.3% in the control group and the study group, respectively). There was significant difference between the two groups (P <0.05). The study group was significantly lower than the control group in the adverse reaction rate (adverse reaction rates were 13.3% and 3.3% in the control group and the study group). Conclusion Oxaliplatin in the treatment of gastric cardia cancer with high efficacy and high remission rate is worthy of promotion and application in clinic.